Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
Kimberlin DW, Acosta EP, Sánchez PJ, Sood S, Agrawal V, Homans J, Jacobs RF, Lang D, Romero JR, Griffin J, Cloud GA, Lakeman FD, Whitley RJ; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Kimberlin DW, et al. Among authors: whitley rj.
J Infect Dis. 2008 Mar 15;197(6):836-45. doi: 10.1086/528376.
J Infect Dis. 2008.
PMID: 18279073
Clinical Trial.